An intensive tobacco dependence intervention based on selfdetermination theory that targeted all smokers was cost-effective and facilitated patient autonomy, perceived competence, and long-term tobacco abstinence.
A 7.6% improvement in 12-month cholesterol refill was observed among US military veterans randomized to an adherence blister packaging intervention versus an education-only intervention.
Adults 20 years or older were surveyed regarding advance directives (ADs); one third had completed an AD. Subjects were comfortable with provider initiation of the topic.
Although we found no DCIS treatment disparities by race/ethnicity, use of adjuvant radiation therapy was less among older women and among residents of poorer neighborhoods.
Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.
Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.
This case study from the American Cancer Society (ACS) describes the ACS’s Health Insurance Assistance Service and offers profiles of 2 cases, which describe the challenges of finding adequate and affordable solutions, as well as sharing lessons learned.
Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.
The actual costs of implementing the evidence-based Diabetes Prevention Program (DPP) were compared with the latest reimbursement rates provided by CMS.
Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
Ambulatory care–sensitive conditions can be systematically assessed in a large electronic medical database to describe admission rates by year, catchment area, and hospital affiliation.
Widespread adoption of evidence-based protocols and healthy lifestyles provide a combined opportunity to reduce up to $1 trillion of current healthcare spending.
Findings from a systematic evidence review of the medical home are promising, but indicate the critical need for stronger evaluations to guide policy makers.
Cost sharing for medications presents a serious access barrier for many blood cancer patients. Available solutions, if embraced by policymakers, could reduce such cost sharing with very little impact on premiums.
The authors provide a framework to capture additional benefits that may result from VBID programs, extending beyond utilization and outcomes to productivity, engagement, and talent.